Expansion of standard manufacturing rules on drugs, etc. eyed

The Korea Food and Drug Administration said it would expand the scope of the standard manufacturing rules on drugs, etc. as part of measures to promote over-counter-drugs (OTCs) in the domestic pharmaceutical industry, while ensuring better financial stability in the national health insurance scheme.

The rules are intended for standardizing the kinds of drug components, specification, conten...